SPX4,076.57-3.54 -0.09%
DIA344.41-1.74 -0.50%
IXIC11,482.45+14.45 0.13%

BRIEF-Inmed Pharmaceuticals Advances Neurodegenerative Disease Program

Reuters · 11/16/2022 07:30
BRIEF-Inmed Pharmaceuticals Advances Neurodegenerative Disease Program

-

  • INMED PHARMACEUTICALS ADVANCES NEURODEGENERATIVE DISEASE PROGRAM WITH NATURAL SCIENCES AND ENGINEERING RESEARCH COUNCIL OF CANADA ("NSERC") ALLIANCE GRANT FUNDING

Source text for Eikon: ID:

Further company coverage: INM.O


((Reuters.Briefs@thomsonreuters.com;))